| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$109 |
June 2025 Quarterly Activities Report & Cashflow Report
|
21 Jul 2025 9:07AM |
$0.018 |
$0.032 |
risen by
77.78%
|
|
SRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Stellar Resources Limited released its Quarterly Activities Report and Cashflow Report for the quarter ending June 2025.
- The Heemskirk Tin Project remains the company’s focus, with ongoing exploration and feasibility work.
- Significant progress was made on advancing the project’s permitting, environmental assessments, and technical studies.
- The company continued engagement with key stakeholders and government authorities to support project development.
- Cash outflows for the quarter were mainly attributed to exploration and evaluation expenditures.
- Stellar Resources reported its cash position at the end of the quarter and outlined expected cash outflows for the next quarter.
- No mining production or revenue was recorded during the quarter as the project is still in the development phase.
- The report included statements on compliance with ASX Listing Rules and confirmations regarding related party transactions.
- Stellar Resources aims to unlock value from the Heemskirk Tin Project and is actively seeking to progress toward project financing and development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$31 |
Cleansing Notice
|
21 Jul 2025 9:07AM |
$0.044 |
$0.025 |
fallen by
43.18%
|
|
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$32 |
High-grade silver results received from resource drilling
|
21 Jul 2025 9:06AM |
$0.195 |
$0.400 |
risen by
105.13%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade silver assay results received from resource drilling at the Orient Silver Project.
- Drilling targeted the Orient West and Orient East lodes.
- Multiple significant intersections confirm high-grade silver mineralisation.
- Results support the company's progress towards a maiden JORC mineral resource estimate.
- Additional mineralised zones identified, expanding the exploration potential.
- Drilling has improved geological understanding of the mineralised system.
- Results will inform future exploration and development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elsight Limited (ELS) ORDINARY FULLY PAID |
Information Technology |
$1,717 |
Trading halt
|
21 Jul 2025 9:05AM |
$1.925 |
$7.740 |
risen by
302.08%
|
|
ELS - Price-sensitive ASX Announcement
Full Release
Key Points
- Elsight Limited (ELS) has requested a trading halt to be placed on its securities.
- The trading halt is due to a pending announcement regarding a proposed capital raising.
- The halt will remain until the earlier of normal trading on 13 June 2024 or the release of the announcement.
- The request was made to ensure the market is fully informed.
- Relevant correspondence between Elsight Limited and the ASX is included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$277 |
FY25 Results Webinar Notification & 2025 AGM Date
|
21 Jul 2025 9:05AM |
$3.230 |
$2.680 |
fallen by
17.03%
|
|
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,915 |
Update on director relevant interest
|
21 Jul 2025 9:03AM |
$15.070 |
$12.910 |
fallen by
14.33%
|
|
| Elixir Energy Limited (EXR) ORDINARY FULLY PAID |
Energy |
$243 |
Quarterly Activities Report and Appendix 5B Jun 25
|
21 Jul 2025 9:02AM |
$0.029 |
$0.130 |
risen by
348.28%
|
|
EXR - Price-sensitive ASX Announcement
Full Release
Key Points
- EXR focused on gas exploration and appraisal in Mongolia's Nomgon IX CBM PSC.
- The company reported positive drilling and testing results, indicating potentially commercial gas flow rates.
- Progress continued on green hydrogen and renewable energy initiatives, including feasibility studies and partnerships.
- Ongoing discussions and engagement with Mongolian government authorities to secure project approvals and support.
- Financial data and cash flow disclosures are included through the Appendix 5B for the reporting quarter.
- Operational expenditures were detailed, reflecting investment in both exploration and project development.
- EXR's forward work programs remain focused on unlocking value from coal seam gas and renewable energy resources.
- The company highlighted its commitment to sustainable energy solutions and continued stakeholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$12 |
Proposed issue of securities - DUN
|
21 Jul 2025 9:02AM |
$0.019 |
$0.050 |
risen by
163.16%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$739 |
Weekly Estimate NTA for 18.07.2025
|
21 Jul 2025 9:01AM |
$3.020 |
$3.550 |
risen by
17.55%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$24 |
Final US FDA De Novo Clearance Submission Completed
|
21 Jul 2025 9:01AM |
$0.039 |
$0.115 |
risen by
194.87%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- PainChek Ltd has completed its final US FDA De Novo submission for its PCK product.
- PCK is an AI-driven medical device for pain assessment, particularly for individuals with communication difficulties.
- Final submission follows extensive clinical validation, technical development, and regulatory preparations.
- Achieving FDA De Novo clearance is expected to open the large US market to PainChek.
- The submission includes comprehensive technical, clinical, and safety evidence.
- PainChek’s solution addresses an unmet clinical need in pain management.
- Company plans to leverage its global market experience and US partnerships for commercial launch.
- Announcement marks a major milestone in PainChek's global expansion strategy.
- PainChek’s US regulatory pathway involves a rigorous review process with a focus on product safety and efficacy.
- The company expresses confidence in its product and regulatory submission, anticipating significant market impact upon approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Harvest Technology Group Ltd (HTG) ORDINARY FULLY PAID |
Information Technology |
$19 |
Investor Webinar
|
21 Jul 2025 9:01AM |
$0.015 |
$0.012 |
fallen by
20%
|
|
| Helios Energy Ltd (HE8) ORDINARY FULLY PAID |
Energy |
$6 |
Oil Production Restart and US Appointments
|
21 Jul 2025 9:00AM |
$0.021 |
$0.002 |
fallen by
92.86%
|
|
HE8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Helios Energy Ltd restarts oil production at the Presidio Oil Project in Texas
- US regulatory approvals and wellwork activities completed
- Appointment of David J. Mankin as President of US Operations
- Appointment of Charles D. Smith as Vice President of Operations
- Strengthened US operational and technical team
- Focus on maximising operational efficiency and production
- Production restart intended as foundation for further asset development
- Commitment to driving shareholder value with expanded US presence
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$95 |
Update - Notification of buy-back - CAM
|
21 Jul 2025 9:00AM |
$0.700 |
$0.675 |
fallen by
3.57%
|
|
| Lode Resources Ltd (LDR) ORDINARY FULLY PAID |
Materials |
$17 |
Tin Enhances High-Grade Antimony and Silver Intercepts
|
21 Jul 2025 8:59AM |
$0.135 |
$0.086 |
fallen by
36.30%
|
|
LDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Lode Resources Ltd reported significant tin mineralization at the Webbs Consol Silver Project in New South Wales.
- The new assays enhance previously reported high-grade antimony and silver intercepts.
- Tin represents a third critical metal at the project, improving its economic potential.
- High-grade intersections at Tangoa West Lode include substantial silver, antimony, and tin values.
- The results are significant given global supply shortages for antimony and tin.
- Further drilling and metallurgical work are planned to assess the recoverability and extent of tin.
- The company aims to establish Webbs Consol as a major multi-commodity resource with strategic critical metals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tlou Energy Limited (TOU) ORDINARY FULLY PAID |
Energy |
$3 |
Board Changes and Appointment of Non-Executive Director
|
21 Jul 2025 8:59AM |
$0.025 |
$0.002 |
fallen by
92%
|
|
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$9 |
DUN:Dundas secures large 612km2 of Gerry Well Greenstone ELs
|
21 Jul 2025 8:59AM |
$0.022 |
$0.034 |
risen by
54.55%
|
|
TMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dundas Minerals Limited has been granted two Exploration Licences covering 612km2 in the Gerry Well Greenstone Belt, Western Australia.
- The region is considered highly prospective for nickel, lithium, gold, and rare earth elements.
- The acquisition aligns with Dundas' strategy to focus on critical minerals essential for clean energy and battery technologies.
- Historical exploration data indicate significant mineral potential, and Dundas plans to utilize both legacy and contemporary exploration methods.
- The company’s exploration strategy includes geophysical surveys, geochemical sampling, and targeted drilling programs.
- Dundas emphasizes responsible exploration practices, with commitments to environmental stewardship and engagement with local communities and stakeholders.
- The announcement highlights the scarcity of underexplored greenstone belts in Western Australia and the competitive advantage Dundas gains through these new tenements.
- The company intends to fast-track exploration activities to identify and develop potential mineral resources.
- Dundas Minerals’ leadership believes this acquisition significantly enhances their exploration portfolio and growth prospects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$12 |
Dundas secures large 612km2 of Gerry Well Greenstone ELs
|
21 Jul 2025 8:59AM |
$0.019 |
$0.050 |
risen by
163.16%
|
|
DUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Dundas Minerals Limited has secured a large exploration license (EL) covering 612 km² in the Gerry Well Greenstone Belt.
- The area is located in Western Australia and is considered prospective for nickel, copper, cobalt, and gold.
- Historical exploration and recent geophysical data indicate significant mineral potential.
- The acquisition expands Dundas's strategic landholding in a proven mineralized region.
- Dundas intends to undertake systematic exploration activities, including geophysical and geochemical surveys, and drilling.
- The announcement is consistent with Dundas's strategy to explore underexplored but promising terrains.
- The newly acquired tenements complement existing projects and enhance Dundas's exploration portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Norwood Systems Limited (NOR) ORDINARY FULLY PAID |
Information Technology |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
21 Jul 2025 8:59AM |
$0.025 |
$0.023 |
fallen by
8%
|
|
NOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Appendix 4C Cash Flow Report released for quarter ending 30 June 2023
- Focus on commercialization of AI-driven Compass platform for enterprise and government markets
- Secured multiple pilot projects with blue-chip organizations
- Continued enhancement of technology stack and AI capabilities
- Efforts to convert pilot programs into recurring paid contracts
- Significant reduction in operating expenses and cash burn
- Successful placement completed to strengthen capital position
- Prudent cash management and ongoing cost optimization
- Commitment to delivering innovation and supporting digital transformation
- Ongoing engagement with clients and pursuit of revenue growth opportunities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$93 |
Q4 FY25 Results Investor Briefing
|
21 Jul 2025 8:58AM |
$0.065 |
$0.098 |
risen by
50.77%
|
|
| ARC Funds Limited (ARC) ORDINARY FULLY PAID |
Financials |
$6 |
Change in substantial holding
|
21 Jul 2025 8:58AM |
$0.105 |
$0.075 |
fallen by
28.57%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$568 |
Weekly NTA 18.07.2025
|
21 Jul 2025 8:57AM |
$3.070 |
$2.550 |
fallen by
16.94%
|
|
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$101 |
High-Grade Au in Rock Chips at Sybil
|
21 Jul 2025 8:57AM |
$0.010 |
$0.028 |
risen by
180%
|
|
SHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sunshine Metals Limited reports high-grade gold in rock chips at Sybil prospect, Queensland.
- Rock chip assays returned up to 19.6 g/t Au.
- Sybil is part of the Ravenswood Consolidated Project.
- Gold mineralization remains open and underexplored.
- Further exploration including mapping, soil sampling, and drilling is planned.
- Sybil prospect considered a high-priority target within the company's exploration portfolio.
- Announcement reinforces Sunshine Metals’ focus on advancing gold exploration opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$93 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
21 Jul 2025 8:56AM |
$0.065 |
$0.098 |
risen by
50.77%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited (LDX) provided its quarterly activities report and Appendix 4C cash flow for the quarter ending 30 September 2023.
- Revenue for the quarter was $1.5 million, primarily from services, Lumos-branded products, and prototype sales, with an additional $0.9 million from government grants.
- The company completed the sale of its US-based subsidiary, RPS Diagnostics, to Biosynex S.A. for US$8.0 million, with $6.7 million received after customary adjustments.
- Lumos executed a strategic review, resulting in a focus on core business, divestment of non-core assets, and cost reductions, including a restructuring of its US workforce.
- Significant progress was made in preparing the FDA resubmission for the FebriDx® test, with additional research and analytical studies being completed.
- The company ended the quarter with a cash balance of $14.7 million and expects further cost reductions and improved profitability following the strategic review.
- Operating cash outflows for the quarter were $3.7 million, reflecting ongoing product development, regulatory activities, and restructuring.
- Lumos continues its efforts to expand into international markets and seeks partnerships and grant opportunities to support the commercialization of its products.
- FDA re-submission for FebriDx® is targeted for the second quarter of FY24, pending completion of new analytical and clinical data requirements.
- The company is prioritizing profitability and sustainable growth through tighter cost controls and focusing on its core diagnostics business.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IRESS Limited (IRE) ORDINARY FULLY PAID |
Information Technology |
$1,179 |
Iress 2025 Half Year Investor Conference Call Details
|
21 Jul 2025 8:56AM |
$7.710 |
$6.310 |
fallen by
18.16%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$211 |
Central Gawler Mill Refurbishment Estimated at A$26m
|
21 Jul 2025 8:55AM |
$0.700 |
$0.780 |
risen by
11.43%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Barton Gold Holdings Limited estimates Central Gawler Mill refurbishment at A$26 million.
- The refurbishment is part of a broader strategy to create a central processing hub for regional gold projects.
- Upgrades to the mill are expected to improve production timelines and capital efficiencies.
- The company has outlined a staged development approach and ongoing technical evaluations.
- The Central Gawler Mill is a key asset to support Barton's pathway to gold production in South Australia.
- The announcement emphasizes the strategic importance of the mill within Barton's asset portfolio and future operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
